IV Infusion Pumps for Improved Patient Outcomes - Lawrence General Hospital, an independent, not-for-profit safety-net hospital and the only hospital in Lawrence, Massachusetts, will use a one-time Congressionally Directed Spending award of $1,367,000 to replace its end-of-life fleet of intravenous (IV) infusion pumps with new smart infusion devices. The majority of the hospital’s current pumps are more than 13 years old and well beyond their useful life, and all fall within the scope of an FDA-directed market withdrawal of BD Alaris™ devices running software older than version 12.3, effective October 2026. The project will purchase 301 IV point-of-care units and 501 infusion, syringe, and patient-controlled analgesia modules, configure Guardrails™ dose-error reduction software, complete biomedical acceptance testing, train clinical staff, and decommission legacy equipment within a 12-month period of performance (September 1, 2026 – August 31, 2027). Smart infusion pumps with drug-library decision support help ensure that medications, fluids, and blood products are delivered accurately and safely, reducing the risk of infusion-related medication errors for patients of all ages. The project serves Lawrence – a community with high social vulnerability – and the surrounding communities of Methuen, Andover, North Andover, and Haverhill, where Lawrence General Hospital provides approximately 1,500 births, 12,000 inpatient stays, and more than 67,000 emergency visits each year. This is a non-construction, movable-equipment project; no cost sharing is required or claimed.
